Yuping Yan

Dr. Yuping Yan


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2023 in Frontiers in Plant Science
Verified
Journal Article
Open access
PLPai Liu
Pai Liu
JWJie-Min Wang
Jie-Min Wang
HGHao-Chuan Guo
Hao-Chuan Guo
MZMeng-Wei Zhao
Meng-Wei Zhao
YSYong-Xing Song
Yong-Xing Song
YZYuguang Zheng
Yuguang Zheng
Bombyx batryticatus is derived from the dried larva of Bombyx mori Linnaeus infected by Beauveria bassiana (Bals.) Vuillant. Raw Bombyx batryticatus should be stir-fried before oral administration due to its irritation to the gastrointestinal tract. Nevertheless, it is still an arduous task to uncover the intrinsic mechanism of Bombyx batryticatus processing. In this study, we collected two types of Bombyx batryticatus, one being stir-fried and the other serving as a control. Then, an informative approach, which integrated matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) with chemometrics analysis, was established to screen processing-associated markers and reveal in situ spatial distribution patterns of protein-related metabolites. After optimization of experimental conditions, 21 ions were initially detected from Bombyx batryticatus, including amino acids and peptides. In addition, 15 differential markers were screened by orthogonal projection to potential structure discriminant analysis (OPLS-DA), which were localized and visualized in the transverse section of Bombyx batryticatus by MSI. Eventually, it can be demonstrated that the stir-frying process reduces toxicity while potentially boosting specific biological activities of Bombyx batryticatus. In summary, the established strategy could not only clarify the chemical transformation of protein-related metabolites from Bombyx batryticatus before and after frying with wheat bran, but also reveal the significance of Chinese medicine processing technology.

16 May 2025 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
XFXiangrui Fu
Xiangrui Fu
CLCaihong Li
Caihong Li
MZMengwei Zhao
Mengwei Zhao
YXYulong Xu
Yulong Xu
LGLanping Guo
Lanping Guo
XGXian Gu
Xian Gu

7 January 2025 in Biologia
Verified
Journal Article
Closed access
PDF file
XFXiangrui Fu
Xiangrui Fu
XMXin Meng
Xin Meng
DMDonglai Ma
Donglai Ma
YZYuguang Zheng
Yuguang Zheng
JJJianming Jiang
Jianming Jiang
XGXian Gu
Xian Gu

24 June 2026 in Molecules
Verified
Journal Article
Open access
PDF file
HZHuanyu Zhang
Huanyu Zhang
WZWeiqian Zhang
Weiqian Zhang
FLFangya Li
Fangya Li
XLXinyao Lu
Xinyao Lu
YYYuping Yan
Yuping Yan
DZDan Zhang
Dan Zhang
This study focuses on the synthesis of glucovanillin mediated by UGT109A1 and its mechanism against Type 2 Diabetes Mellitus (T2DM). Recombinant UGT109A1 successfully synthesized glucovanillin from vanillin using UDP-Glc as the sugar donor. Through network pharmacology, 140 potential targets were identified. Seven key targets were further screened using LASSO and SVM-RFE algorithms. Among these, SLC5A1 and ADK showed strong diagnostic potential, with AUC values ranging from 0.85 to 0.89. Immune infiltration analysis linked these core targets to M2 macrophages. Single-cell transcriptomics revealed that ADK is widely expressed but enriched in B cells, while TLR9 is confined to plasmacytoid dendritic cells (pDCs). Cell-to-cell communication analysis identified a pDC-to-B cell signaling axis. In vitro assays demonstrated that glucovanillin exhibits concentration-dependent inhibitory activity against α-glucosidase with moderate potency, with an IC50 of 413.84 ± 12.80 μM. Molecular docking, 200 ns molecular dynamics simulations (MD), and MM/PBSA calculations showed that glucovanillin binds more strongly to α-glucosidase (−7.4 kcal/mol) than vanillin (−5.4 kcal/mol). Therefore, the glycosylation mediated by UGT109A1 enhanced the bioactivity and targeting specificity of vanillin. In summary, glucovanillin exerts anti-T2DM effects through a dual mechanism involving α-glucosidase inhibition and regulation of key targets, making it a promising lead compound for T2DM treatment.